Search research articles
Contact Us
Filters
Showing results (71-80 of 119) with videos related to
Page
of 12
Sort By:
Gynecologic Oncology
|
July 27, 2021
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy
Derman Basaran, Thomas Boerner, Jessa Suhner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2020
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P Tew, Christina Lacchetti, Annie Ellis, et al.
The Oncologist
|
August 18, 2009
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer
Dennis S Chi, Rebecca Phaëton, Thomas J Miner, et al.
Gynecologic Oncology
|
January 22, 2020
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
Karen A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 30, 2018
Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group
Tanya M Wildes, Ronald J Maggiore, William P Tew, et al.
Gynecologic Oncology
|
February 22, 2023
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial
Aaron M Praiss, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology
|
May 23, 2019
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status
Marina Stasenko, Paulina Cybulska, Noah Feit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer
Paul J Sabbatini, Govind Ragupathi, Chandra Hood, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2012
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer
Ursula A Matulonis, Julie Lee, Brian Lasonde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401
Arti Hurria, Constance T Cirrincione, Hyman B Muss, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 119) with videos related to
Sort By:
Page
of 12
Gynecologic Oncology
|
July 27, 2021
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy
Derman Basaran, Thomas Boerner, Jessa Suhner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2020
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P Tew, Christina Lacchetti, Annie Ellis, et al.
The Oncologist
|
August 18, 2009
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer
Dennis S Chi, Rebecca Phaëton, Thomas J Miner, et al.
Gynecologic Oncology
|
January 22, 2020
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
Karen A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 30, 2018
Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group
Tanya M Wildes, Ronald J Maggiore, William P Tew, et al.
Gynecologic Oncology
|
February 22, 2023
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial
Aaron M Praiss, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology
|
May 23, 2019
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status
Marina Stasenko, Paulina Cybulska, Noah Feit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer
Paul J Sabbatini, Govind Ragupathi, Chandra Hood, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2012
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer
Ursula A Matulonis, Julie Lee, Brian Lasonde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401
Arti Hurria, Constance T Cirrincione, Hyman B Muss, et al.
Page
of 12